AgomAb Therapeutics NV (AGMB)
12.14
+0.06
(+0.50%)
USD |
NASDAQ |
Sep 18, 16:00
12.14
0.00 (0.00%)
After-Hours: 18:40
AgomAb Therapeutics Total Assets (Quarterly) : 180.52M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 180.52M |
| Date | Value |
|---|---|
| December 31, 2024 | 213.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | 675.10M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.78M |
| Shareholders Equity (Quarterly) | 153.74M |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.488 |